ASM22 highlights

ASM22 Convenor Dr Melissa Moore and A/Prof Zarnie Lwin

2022 Annual Scientific Meeting Highlights The Dynamic Face of Lung Cancer was certainly showcased at our 2022 Annual Scientific Meeting, with presentations illustrating the latest research and clinical practice in surgery, diagnostics, radiation therapy, targeted therapy, immunotherapy and prevention of risk factors for thoracic cancers. Held as a ‘hybrid’ event, the event attracted 150 face […]

Run and fundraise

Running for #TeamTOGA What is #TeamTOGA? #TeamTOGA is a group of individuals who walk or run to raise money for lung cancer and mesothelioma research by participating in marathons or walking events and collecting donations and sponsors through their own personal fundraising page created by TOGA. #TeamTOGA is reassembling for the 2023 Sun Herald City2Surf, […]

Abstracts

Abstract Submission Guidelines Back to 2023 ASM Abstract Submissions The TOGA Annual Scientific Meeting (ASM) Local Organising Committee (LOC) welcomes abstracts on any scientific study of merit for submission, particularly those that provide new and original data relevant to the Australian and New Zealand environment.  Abstracts may be submitted on any topic relevant to lung […]

Survivorship

Research Prioritisation in Lung Cancer Survivorship With the advent of new and more effective lung cancer treatments in the last 10 years and the emerging data supporting screening, there is, and will continue to be, a growing number of lung cancer survivors who either have had surgery or radiotherapy for early disease, and/or remain on […]

AusCancerPlan

Australian Cancer Plan 2023-2033 The Australian Cancer Plan The Minister for Health and Aged Care, the Hon. Greg Hunt MP, has invited Cancer Australia to develop a modernised Australian Cancer Plan. This recognises the need for an overarching national approach to cancer control that meets the needs of all Australians now and in the future, […]

Teletrials

Mobilising teletrials What are teletrials? Teletrials, also known as digi trials, are when a clinician at a primary site uses telehealth (videoconference or telephone calls) to enrol, consent, treat and/or follow up patients at another site, referred to as a satellite site. However, much of the responsibility for the clinical trial remains at the primary […]

2021wrap

Donate now 2021 wrap up While a trying year on many accounts, 2021 has seen TOGA move from success to success.  The year commenced with the welcome news that TOGA had secured the funding for the remainder of the infrastructure grant provided by Cancer Australia, which was subsequently extended until the end of 2021, with […]

ASM21 highlights

Program PDF 2021 Annual Scientific Meeting Highlights With a theme of ‘Equity and Innovation in Multidisciplinary Lung Cancer Care’, the ASM21 program featured diverse topics designed to appeal to the multidisciplinary audience. Up to 234 registrants viewed the live, virtual program throughout the two days, cementing the TOGA ASM as one the highlights in the […]

City2Surf

Join #TeamTOGA in Sun-Herald City2Surf 17-24 October, 2021Fundraise for lung cancer researchComplete 14km in your neighbourhood TOGA is entering #TeamTOGA in the iconic Sun Herald City2Surf. Due to ongoing COVID-19 concerns, the event will be completed remotely by plotting and completing a 14km course in your own neighbourhood between 17-24 October, 2021. #TeamTOGA will raise […]

ASM21

Program PDF Presenters Register Annual Scientific Meeting 2021 Equity and innovation in multidisciplinary lung cancer careVirtual and OnDemand platform #TOGAASM21 It is with much pleasure that we invite you to register for the inaugural Thoracic Oncology Group of Australasia (TOGA) Annual Scientific Meeting (ASM). While incredibly disappointing for all involved, the current COVID environment will […]